Abstract
Multi drug resistant tuberculosis has come up as a separate disease meriting different diagnostic and therapeutic options from conventional tuberculosis. Worldwide there has been considerable increase in MDRTB cases to 60,000 and less than 5% of them get management as desired by various infectious disease bodies. Another entity titled XMDRTB has of late assumed significant proportion of tuberculosis cases which is steaming into a new health related inferno. Some sporadic cases of tuberculosis have come up which are completely resistant to all anti-tubercular drugs, that should be an area of concern for all healthcare givers. JMS 2016; 19(1):12-17
Highlights
Multi drug resistant tuberculosis has come up as a separate disease meriting different diagnostic and therapeutic options from conventional tuberculosis
Cases of MDR tuberculosis were reported to the World Health Organization (WHO) in 2008, of which less than one fifth were managed according to international guidelines
As per the recent data from WHO the global burden of tuberculosis is stable to decreasing trend depending on geographical variation
Summary
The need of the hour is that every health care individual should be sensitized with a new disease MDRTB, with its clinical course, presentations, suspicion of its occurrence, importance of drug sensitivity testing, appropriate antituberculosis drug combination, adequate treatment duration, contact tracing, complication recognition and its approach lastly in recognition of predisposing factors. In addition to sensitize health care workers it is imperative to make mass awareness programme for common public especially for the family of the affected regarding the need to adherence of drug regimens
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
